The concentration of sclerostin was also significantly increased in RA patients, median (Q1–Q3) 0.63 (0.49–0.78) ng/mL versus controls 0.51 (0.4–0.7) ng/mL (p < 0.01) (Figs. 1c and 2). This evidence concerns the gene SOST and rheumatoid arthritis.